+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UAE In-Vitro Diagnostics Devices Market Report by Application, End-User 2024-2032

  • PDF Icon

    Report

  • 136 Pages
  • April 2024
  • Region: United Arab Emirates
  • IMARC Group
  • ID: 5849856
The UAE in-vitro diagnostics (IVD) devices market size reached US$ 274.7 Million in 2023. Looking forward, the market is projected to reach US$ 415.6 Million by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2023-2032. The robust government healthcare investments fostering advanced technologies and the escalating prevalence of chronic diseases demanding accurate diagnostics for effective management are among the key factors driving the market growth.

In-vitro diagnostic (IVD) devices are medical tools utilized in the analysis of blood, urine, or tissue samples derived from the human body. These devices aid in detecting, monitoring, and managing various medical conditions and diseases. IVD devices provide accurate and timely insights into a patient's health status by employing technologies such as immunoassays, molecular diagnostics, and microbiology. They are crucial in clinical decision-making, enabling healthcare professionals to diagnose diseases, track treatment progress, and tailor therapies. IVD devices are subject to rigorous regulatory standards to ensure their safety, accuracy, and reliability in healthcare settings.

The UAE in-vitro diagnostics devices market is experiencing dynamic growth, driven by the country's commitment to advancing its healthcare infrastructure, coupled with rising demand for accurate and rapid diagnostic solutions. Besides this, the UAE government's focus on promoting medical tourism, a growing aging population, and the increase in prevalence of chronic diseases have elevated the need for efficient and precise diagnostic tools, creating a favorable market outlook.

Additionally, advancements in technology, such as point-of-care testing and molecular diagnostics, and collaborations between local healthcare institutions and global IVD manufacturers are contributing to the market's expansion. Furthermore, regulatory initiatives aimed at ensuring the quality and safety of medical devices are providing lucrative growth opportunities for market expansion.

UAE In-Vitro Diagnostics Devices Market Trends/Drivers

Government investment in healthcare infrastructure

The UAE government's substantial investments in healthcare infrastructure are a pivotal driving force behind the growth of the IVD devices market. Recognizing the crucial role of accurate diagnostics in patient care, the government has embarked on ambitious initiatives to enhance the country's healthcare facilities. This includes the establishment of state-of-the-art hospitals, clinics, and medical centers equipped with advanced diagnostic equipment.

The strategic allocation of funds towards healthcare development ensures the availability of modern medical facilities and fosters the demand for cutting-edge IVD devices. These investments create an environment conducive to adopting and integrating innovative technologies, enabling healthcare professionals to diagnose diseases accurately and promptly.

Prevalence of chronic diseases and lifestyle changes

The increasing prevalence of chronic diseases, exacerbated by changing lifestyles, is a significant driver of the UAE's IVD devices market. Urbanization, sedentary habits, and dietary shifts have led to a rise in non-communicable diseases including diabetes, cardiovascular conditions, and cancer. In response, healthcare providers are prioritizing early diagnosis and management to mitigate the impact of these diseases.

IVD devices, offering a range of tests from molecular diagnostics to biomarker assays, provide invaluable insights into disease markers, genetic predispositions, and treatment responses. This enables healthcare professionals to formulate personalized treatment plans, track disease progression, and optimize interventions. The escalating burden of chronic diseases underscores the critical need for accurate diagnostic tools, fueling the demand for IVD devices in the UAE's healthcare landscape.

UAE In-Vitro Diagnostics Devices Industry Segmentation

This report provides an analysis of the key trends in each segment of the UAE in-vitro diagnostics (IVD) devices market report, along with forecasts for the period 2024-2032. The report has categorized the market based on application and end-user.

Breakup by Application:

  • Infectious Diseases
  • Diabetes
  • Blood Test
  • Nephrology
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Others
Infectious diseases represent the leading application

The report has provided a detailed breakup and analysis of the market based on the application. This includes infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases, and others. According to the report, infectious diseases represented the largest segment.

The utilization of in-vitro diagnostics (IVD) devices in infectious diseases for rapid and accurate diagnostics is positively impacting the market growth. IVD devices help with the timely identification and containment of outbreaks, enhancing public health response. Moreover, the surging adoption of IVD devices in diabetes management to enable regular monitoring of glucose levels, and supporting effective treatment adjustments, is contributing to the market growth. Besides this, in nephrology, precise tests facilitate the early detection of renal dysfunction, enabling timely intervention to prevent complications.

Additionally, the widespread employment of IVD devices in cardiology to provide insights into cardiac markers, guiding risk assessment and treatment strategies, is strengthening the market growth. Furthermore, oncology relies on IVD tools for molecular profiling and monitoring treatment efficacy, and autoimmune diseases are diagnosed and managed through specific biomarker assays, aiding in tailored therapeutic approaches. Across these specialties, IVD devices help in enabling personalized, efficient, and accurate medical interventions, ultimately improving patient outcomes and quality of life.

Breakup by End-User:

  • Hospital-Based Centres
  • Diagnostics Chains
  • Standalone Centres
  • Others
Hospital-based centers account for the majority of the market share

A detailed breakup and analysis of the market based on the end-user has also been provided in the report. This includes hospital-based centers, diagnostics chains, standalone centres, and others. According to the report, hospital-based centers accounted for the largest market share.

The demand for in-vitro diagnostics (IVD) devices in hospital-based centers is propelled by the increasing complexity of medical cases that necessitate comprehensive and precise diagnostic information. Moreover, the shift towards value-based healthcare emphasizes the importance of accurate diagnosis for effective treatment planning, leading to higher adoption of IVD technologies. Additionally, the trend of decentralized testing within hospitals, enabling faster turnaround times, aligns with the capabilities of IVD devices.

Concurrent with this, the rising patient volume in hospital settings requires streamlined and automated diagnostics to manage the workload effectively. As hospitals aim to enhance patient outcomes and optimize resource utilization, IVD devices offer invaluable support in aiding clinical decision-making, accelerating diagnosis and improving patient care within the hospital environment.

Competitive Landscape

The competitive landscape of the UAE in-vitro diagnostics devices market is characterized by a dynamic interplay of domestic and international players. Key multinational corporations bring their established expertise and technological prowess, often collaborating with local distributors to penetrate the market effectively. These global entities hold a significant share owing to their extensive product portfolios and established reputations.

Concurrently, a growing number of local companies are emerging as important contenders, driven by the UAE's emphasis on healthcare innovation and its strategic support for homegrown enterprises. Regulatory compliance, product quality, and customer support remain crucial factors in this competitive landscape as market players vie to offer solutions that align with the UAE's rapidly evolving healthcare ecosystem.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Key Questions Answered in This Report

  • How has the UAE in-vitro diagnostics devices market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the UAE in-vitro diagnostics devices market?
  • What is the impact of each driver, restraint, and opportunity on the UAE in-vitro diagnostics devices market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the UAE in-vitro diagnostics devices market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the UAE in-vitro diagnostics devices market?
  • What is the competitive structure of the UAE in-vitro diagnostics devices market?
  • Who are the key players/companies in the UAE in-vitro diagnostics devices market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 UAE In-Vitro Diagnostics Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by End-User
5.5 Market Breakup by Application
5.6 Market Forecast
5.7 SWOT Analysis
5.7.1 Overview
5.7.2 Strengths
5.7.3 Weaknesses
5.7.4 Opportunities
5.7.5 Threats
5.8 Value Chain Analysis
5.8.1 Overview
5.8.2 Research and Development
5.8.3 Component Manufacturing
5.8.4 Assembling
5.8.5 Distribution
5.8.6 End-Use Industries
5.8.7 Retailer
5.8.8 Consumer
5.9 Porters Five Forces Analysis
5.9.1 Overview
5.9.2 Bargaining Power of Buyers
5.9.3 Bargaining Power of Suppliers
5.9.4 Degree of Competition
5.9.5 Threat of New Entrants
5.9.6 Threat of Substitutes
6 Market Breakup by End-User
6.1 Hospital-Based Centres
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Diagnostics Chains
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Standalone Centres
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Application
7.1 Infectious Diseases
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diabetes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Blood Test
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Nephrology
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Cardiology
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Oncology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Autoimmune Diseases
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Others
7.8.1 Market Trends
7.8.2 Market Forecast
8 Competitive Landscape
8.1 Market Structure
8.2 Key Players
List of Figures
Figure 1: UAE: In-Vitro Diagnostics Devices Market: Major Drivers and Challenges
Figure 2: UAE: In-Vitro Diagnostics Devices Market: Sales Value (in Million US$), 2018-2023
Figure 3: UAE: In-Vitro Diagnostics Devices Market: Breakup by End-User (in %), 2023
Figure 4: UAE: In-Vitro Diagnostics Devices Market: Breakup by Application (in %), 2023
Figure 5: UAE: In-Vitro Diagnostics Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 6: UAE: In-Vitro Diagnostics Devices Industry: SWOT Analysis
Figure 7: UAE: In-Vitro Diagnostics Devices Industry: Value Chain Analysis
Figure 8: UAE: In-Vitro Diagnostics Devices Industry: Porter’s Five Forces Analysis
Figure 9: UAE: In-Vitro Diagnostics Devices (Hospital-Based Centres) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: UAE: In-Vitro Diagnostics Devices (Hospital-Based Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: UAE: In-Vitro Diagnostics Devices (Diagnostics Chains) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: UAE: In-Vitro Diagnostics Devices (Diagnostics Chains) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: UAE: In-Vitro Diagnostics Devices (Standalone Centres) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: UAE: In-Vitro Diagnostics Devices (Standalone Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: UAE: In-Vitro Diagnostics Devices (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: UAE: In-Vitro Diagnostics Devices (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: UAE: In-Vitro Diagnostics Devices (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: UAE: In-Vitro Diagnostics Devices (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: UAE: In-Vitro Diagnostics Devices (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: UAE: In-Vitro Diagnostics Devices (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: UAE: In-Vitro Diagnostics Devices (Blood Test) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: UAE: In-Vitro Diagnostics Devices (Blood Test) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: UAE: In-Vitro Diagnostics Devices (Nephrology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: UAE: In-Vitro Diagnostics Devices (Nephrology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: UAE: In-Vitro Diagnostics Devices (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: UAE: In-Vitro Diagnostics Devices (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: UAE: In-Vitro Diagnostics Devices (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: UAE: In-Vitro Diagnostics Devices (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: UAE: In-Vitro Diagnostics Devices (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: UAE: In-Vitro Diagnostics Devices (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: UAE: In-Vitro Diagnostics Devices (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: UAE: In-Vitro Diagnostics Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
Table 1: UAE: In-Vitro Diagnostics Devices Market: Key Industry Highlights, 2023 and 2032
Table 2: UAE: In-Vitro Diagnostics Devices Market Forecast: Breakup by End-User (in Million US$), 2024-2032
Table 3: UAE: In-Vitro Diagnostics Devices Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: UAE: In-Vitro Diagnostics Devices Market: Competitive Structure

Methodology

Loading
LOADING...

Table Information